N-OXYGENATION OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE BY THE RAT-LIVER FLAVIN-CONTAINING MONOOXYGENASE EXPRESSED IN YEAST-CELLS

被引:6
作者
CHIBA, K [1 ]
KOBAYASHI, K [1 ]
ITOH, K [1 ]
ITOH, S [1 ]
CHIBA, T [1 ]
ISHIZAKI, T [1 ]
KAMATAKI, T [1 ]
机构
[1] HOKKAIDO UNIV,FAC PHARMACEUT SCI,DIV DRUG METAB,SAPPORO,HOKKAIDO 060,JAPAN
来源
EUROPEAN JOURNAL OF PHARMACOLOGY-ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY SECTION | 1995年 / 293卷 / 01期
关键词
MPTP (1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; N-OXYGENATION; FMO (RECOMBINANT RAT LIVER FLAVIN-CONTAINING MONOXYGENASE); FMO1A1;
D O I
10.1016/0014-2999(95)90119-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
N-oxygenation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a dopaminergic neurotoxin, was studied using recombinant rat liver flavin-containing monooxygenase (FMO), FMO1A1, expressed in yeast cells. The mean (+/-S.D.) kinetic parameters of MPTP N-oxygenation were: K-m = 1.8 +/- 0.5 mu M, V-max = 9.5 +/- 1.6 nmol/mg per min, and V-max/K-m = 5.6 +/- 0.5 ml/mg per min. n-Octylamine, an activator of FMO, enhanced the MPTP N-oxygenation activity by 51%, while methimazole, thiobenzamide and alpha-naphthylthiourea, alternate substrates of FMO, inhibited it by 27.4, 68.0 and 59.2%, respectively. The results indicate that MPTP is efficiently N-oxygenated by the recombinant rat liver FMO1A1, and that the responses to the modulators of FMO activity found in the recombinant rat liver FMO1A1 resemble those of mouse and rat liver microsomes as reported previously. The findings suggest that the recombinant FMO expressed in yeast cells is considered as a useful tool to study an involvement of FMO in the metabolism of environmental toxins or chemicals. In addition, FMO1A1 appears to be one of the predominant enzymes responsible for the N-oxygenation of MPTP at least in rat liver.
引用
收藏
页码:97 / 100
页数:4
相关论文
共 16 条
[1]  
CASHMAN JR, 1986, MOL PHARMACOL, V29, P163
[2]  
CHIBA K, 1988, J PHARMACOL EXP THER, V246, P1108
[3]   EFFECTS OF N-METHYLMERCAPTOIMIDAZOLE ON THE DISPOSITION OF MPTP AND ITS METABOLITES IN MICE [J].
CHIBA, K ;
HORII, H ;
KUBOTA, E ;
ISHIZAKI, T ;
KATO, Y .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 180 (01) :59-67
[4]   METABOLISM OF THE NEUROTOXIC TERTIARY AMINE, MPTP, BY BRAIN MONOAMINE-OXIDASE [J].
CHIBA, K ;
TREVOR, A ;
CASTAGNOLI, N .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (02) :574-578
[5]  
CHIBA K, 1985, DRUG METAB DISPOS, V13, P342
[6]   EFFECTS OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) AND SEVERAL OF ITS ANALOGS ON THE DOPAMINERGIC NIGROSTRIATAL PATHWAY IN MICE [J].
HEIKKILA, RE ;
MANZINO, L ;
CABBAT, FS ;
DUVOISIN, RC .
NEUROSCIENCE LETTERS, 1985, 58 (01) :133-137
[7]   THE MAMMALIAN FLAVIN-CONTAINING MONOOXYGENASES - MOLECULAR CHARACTERIZATION AND REGULATION OF EXPRESSION [J].
HINES, RN ;
CASHMAN, JR ;
PHILPOT, RM ;
WILLIAMS, DE ;
ZIEGLER, DM .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1994, 125 (01) :1-6
[8]   RAT-LIVER FLAVIN-CONTAINING MONOOXYGENASE (FMO) - CDNA CLONING AND EXPRESSION IN YEAST [J].
ITOH, K ;
KIMURA, T ;
YOKOI, T ;
ITOH, S ;
KAMATAKI, T .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1173 (02) :165-171
[9]   PARGYLINE PREVENTS MPTP-INDUCED PARKINSONISM IN PRIMATES [J].
LANGSTON, JW ;
IRWIN, I ;
LANGSTON, EB ;
FORNO, LS .
SCIENCE, 1984, 225 (4669) :1480-1482
[10]  
LANGSTON JW, 1986, CLIN NEUROL, V9, P487